| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/18/2003 | WO2003104485A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/18/2003 | WO2003104236A1 Calcitonin gene related peptide receptor antagonists |
| 12/18/2003 | WO2003103771A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 12/18/2003 | WO2003103723A2 Neutrophil imaging methods in cyctic fibrosis |
| 12/18/2003 | WO2003103722A1 New agents for magnetic imaging method |
| 12/18/2003 | WO2003103631A1 Novel high viscosity embolizing compositions comprising prepolymers |
| 12/18/2003 | WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/18/2003 | WO2003103587A2 Compounds or agents that inhibit and induce the formation of focal microvessel dilatations |
| 12/18/2003 | WO2003103569A2 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 12/18/2003 | WO2003075961A3 Gold nanoparticles used for x-rays imaging |
| 12/18/2003 | WO2003049599A3 Methods and compositions for the diagnosis of asthma |
| 12/18/2003 | WO2003045308A3 Formulations for use in medical or diagnostic procedures |
| 12/18/2003 | WO2003015829A3 Methods of determining the effects of toxins |
| 12/18/2003 | WO2003000864A8 Nucleic acid-associated proteins |
| 12/18/2003 | WO2002085417A3 Methods and devices for moisturizing hyperpolarized noble gases and pharmaceutical products thereof |
| 12/18/2003 | WO2002057492A9 Methods and compositions for detecting polynucleotide duplex damage |
| 12/18/2003 | WO2002043775A3 Paramagnetic metal ion-based macrocyclic contrast agents |
| 12/18/2003 | US20030233669 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
| 12/18/2003 | US20030233045 Solid hydrogel coupling for ultrasound imaging and therapy |
| 12/18/2003 | US20030232887 Preparation and use of a stable formulation of allosteric effector compounds |
| 12/18/2003 | US20030232819 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions |
| 12/18/2003 | US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders |
| 12/18/2003 | US20030232084 Administering parenterally effective dose of iron oxide complex with polyol or polyether formulated in biocompatible liquid so that upon administration provides minimal detectable free iron in and minimal incidence of anaphylaxis |
| 12/18/2003 | US20030232053 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 12/18/2003 | US20030232017 Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them |
| 12/18/2003 | US20030232016 Incising tissue of to expose a surgical site having a nerves; adding an indicator; allowing indicator to accumulate in nerves of at surgical site; identifying nerves containing indicator; performing a surgical procedure at surgical site |
| 12/18/2003 | US20030232013 Bringing cancer cell into contact with a peptide-agent complex, wherein peptide comprises an heat stable enterotoxin (ST) motif that binds to breast cancer cells, prostate cancer cells, pancreatic cancer cells or melanoma cancer cells |
| 12/18/2003 | US20030232012 For use as in vivo contrast media in nuclear spin tomography (MRT), as blood-pool agents and as lymphographic agents |
| 12/18/2003 | CA2488753A1 Neutrophil imaging methods in cyctic fibrosis |
| 12/18/2003 | CA2488227A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/18/2003 | CA2487943A1 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/18/2003 | CA2485709A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 12/17/2003 | EP1370655A2 Secreted human proteins |
| 12/17/2003 | EP1370291A1 Device and method for the photodynamic diagnosis of tumor tissue |
| 12/17/2003 | EP1370249A1 Novel dendriticpolymers and their biomedical uses |
| 12/17/2003 | EP1283842B1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation |
| 12/17/2003 | CN1461657A Bone powder mixture and X-ray contras-medium and producing method thereof |
| 12/17/2003 | CN1131071C Tissue anoxia developing agent and its precursor |
| 12/16/2003 | US6664385 Kidney injury-related molecules |
| 12/16/2003 | US6663872 Immune response |
| 12/16/2003 | US6663847 Administering to mammal effective amount of cyanine dye for performing diagnostic or therapeutic procedure |
| 12/16/2003 | US6663846 Devices and methods for monitoring drug therapy compliance |
| 12/16/2003 | CA2202167C Molecular tagging system |
| 12/11/2003 | WO2003102593A1 Methods for avoiding renal injury |
| 12/11/2003 | WO2003102029A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
| 12/11/2003 | WO2003101948A2 Agents for imaging and diagnostic methods using them |
| 12/11/2003 | WO2003101919A2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 12/11/2003 | WO2003101530A2 Solid hydrogel coupling for ultrasound imaging and therapy |
| 12/11/2003 | WO2003101486A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 12/11/2003 | WO2003101484A1 Compositions and methods for transepithelial molecular transport |
| 12/11/2003 | WO2003101427A1 Immunoliposomes formed with aggregated antibody |
| 12/11/2003 | WO2003101279A2 Magnetic resonance imaging of metal concentrations |
| 12/11/2003 | WO2003101188A1 Chronic stress-related disease model animal and method of constructing the same |
| 12/11/2003 | WO2003101187A1 Animal model for toxicology and dose prediction |
| 12/11/2003 | WO2003016923A3 Hydroxypyridonate and hydroxypyrimidinone chelating agents |
| 12/11/2003 | WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 12/11/2003 | US20030229907 Transgenic non-human mammals with progressive neurologic disease |
| 12/11/2003 | US20030229903 Novel system for the evaluation of the activity and/or specificity of a viral component |
| 12/11/2003 | US20030229280 Contrast Medium for Use in Imaging Methods |
| 12/11/2003 | US20030229107 Magnetic resonance with stimulation |
| 12/11/2003 | US20030229034 Drug delivery; nucleic acids; complexing |
| 12/11/2003 | US20030229010 Antidiabetic agents; water in oil microemulsion; immobilization |
| 12/11/2003 | US20030229006 Amphiphilic oligomers |
| 12/11/2003 | US20030228647 Composition for monitoring exocrine function and detecting pancreatitis and pancreatic cancer |
| 12/11/2003 | US20030228273 Novel high viscosity embolizing compositions comprising prepolymers |
| 12/11/2003 | US20030228262 Diagnosis, therapy, image of celluloar disorders; antitumor agents |
| 12/11/2003 | US20030228261 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/11/2003 | US20030228260 Drug delivery; central nervous system disorders |
| 12/11/2003 | US20030228259 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 12/11/2003 | US20030228256 Suppress lymphocyte response; therapy for autoimmune disease, antidiabetic agents |
| 12/11/2003 | US20030228254 Contrast agents |
| 12/11/2003 | CA2488219A1 Agents for imaging and diagnostic methods using them |
| 12/11/2003 | CA2486548A1 Animal model for toxicology and dose prediction |
| 12/11/2003 | CA2484515A1 Solid hydrogel coupling for ultrasound imaging and therapy |
| 12/10/2003 | EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/10/2003 | EP1369134A1 New agents for magnetic imaging method |
| 12/10/2003 | EP1368065A1 Paramagnetic nanoparticle |
| 12/10/2003 | EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 12/10/2003 | EP1367944A1 Patch for screening the sensitivity state of a subject with respect to an allergen and use thereof |
| 12/10/2003 | EP1367886A2 Scce modified transgenic mammals and their use as models of human disease |
| 12/10/2003 | EP0983230B1 Yellow polymorph of 5-amino-2,4,6-triiodo-n,n'-bis(2,3-dihydroxypropyl)-isophthalamide |
| 12/10/2003 | EP0896655B1 High volume hyperpolarizer for spin-polarized noble gas |
| 12/09/2003 | US6662041 Imageable biopsy site marker |
| 12/09/2003 | US6662040 Methods of photoacoustic imaging |
| 12/09/2003 | US6662038 Method and apparatus for imaging abdominal aorta and aortic aneurysms |
| 12/09/2003 | US6660345 Thermochromic liquid crystalline medium |
| 12/09/2003 | US6660301 Injectable microspheres for dermal augmentation and tissue bulking |
| 12/09/2003 | US6660248 Water solubility; medical diagnosis |
| 12/04/2003 | WO2003099783A2 Tropane compounds |
| 12/04/2003 | WO2003099716A1 Method of preparing aqueous fullerene solution or dispersion |
| 12/04/2003 | WO2003099347A1 Cell delivery fluid for prevention of cell settling in delivery system |
| 12/04/2003 | WO2003099130A1 Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging |
| 12/04/2003 | WO2003075977A3 Agglomerated particles for aerosol drug delivery |
| 12/04/2003 | WO2003070173A3 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 12/04/2003 | WO2003061593A3 Novel targeted compositions for diagnostic and therapeutic use |
| 12/04/2003 | WO2003050499A3 Use of a labeled ligand having human cd4 specificity |
| 12/04/2003 | WO2003015626A3 Method and device for determining a characteristic value relating to the blood circulation of modified tissue regions in organs of living beings |
| 12/04/2003 | WO2003006625A3 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 12/04/2003 | WO2002083381A3 Method and compositions for inhibiting cellulolytic symbionts |
| 12/04/2003 | US20030226157 Transgenic rodent which functions as evaluative tool when monitoring the effects of viricides on DNA viruses that induce hyperproliferative lesions in oral and urogenital epithelial tissues; immunotherapy |